Tilray Brands Reconfirms Strategy to Regain Nasdaq Compliance; Requests Extension to Meet Listing Requirements
Rhea-AI Summary
Tilray Brands (Nasdaq: TLRY) has submitted an application for an extension to regain compliance with Nasdaq's minimum share price listing requirements. The company is considering several options, including a potential stockholder-approved Reverse Stock Split to maintain its Nasdaq listing.
CEO Irwin Simon noted that Tilray's stock has seen recent appreciation following President Trump's cannabis rescheduling review, which he believes reflects investor confidence in the company's global platform. The company aims to leverage its position in cannabis, beverage, and wellness industries while giving the market additional time to recognize its business strategy value.
Positive
- None.
Negative
- Risk of potential delisting from Nasdaq due to share price non-compliance
- Possible reverse stock split which could be viewed negatively by market
- Regulatory uncertainty affecting business operations
News Market Reaction
On the day this news was published, TLRY declined 5.60%, reflecting a notable negative market reaction. Argus tracked a peak move of +3.8% during that session. Argus tracked a trough of -22.1% from its starting point during tracking. Our momentum scanner triggered 23 alerts that day, indicating elevated trading interest and price volatility. This price movement removed approximately $89M from the company's valuation, bringing the market cap to $1.50B at that time. Trading volume was elevated at 2.2x the daily average, suggesting increased selling activity.
Data tracked by StockTitan Argus on the day of publication.
NEW YORK and LEAMINGTON, Ontario, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today announced that the Company has submitted an application requesting an extension to regain compliance with Nasdaq’s listing standards regarding its price per share. The Company is evaluating several options including, but not limited to, a stockholder-approved Reverse Stock Split to address capital structure and maintain adherence to Nasdaq’s continued listing requirements.
Irwin Simon, Chief Executive Officer, Tilray Brands, stated, “Tilray’s trading levels have appreciated in recent weeks following President Trump’s review of cannabis rescheduling. We believe this market reaction reflects investors’ confidence in Tilray’s diversified global platform and our ability to capitalize on a more favorable regulatory environment. Tilray is a leader in cannabis, beverage, and wellness, and our growth potential extends beyond any single regulatory change. We are pleased to see investors more accurately recognizing the intrinsic value of our differentiated business portfolio. Tilray has multiple options to meet Nasdaq’s requirements, and with this extension request, we are giving the market additional time to demonstrate its confidence in our long-term strategy. We are building the future of consumer goods at Tilray, creating value for our customers, patients, and shareholders through a commitment to innovation at global scale.”
About Tilray Brands
Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. Tilray’s mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy and create memorable experiences. Tilray’s unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.
For more information on how we are elevating lives through moments of connection, visit Tilray.com and follow @Tilray on all social platforms.
Forward-Looking Statements
Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations concerning, among other things the timing, ratio and completion of the Reverse Stock Split and expected strategic benefits and cost savings. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws.
Contacts:
Investor Relations
investors@tilray.com
Pro-TLRY@prosek.com
Media
news@tilray.com
FAQ
Why is Tilray (TLRY) requesting a Nasdaq listing extension?
What options is Tilray considering to maintain its Nasdaq listing?
How has cannabis rescheduling affected Tilray's stock?
What are Tilray's main business segments in 2025?
What happens if Tilray fails to meet Nasdaq listing requirements?
